Eli Lilly's stock is undervalued; defensive healthcare stocks shine amid uncertainty, and Eli Lilly drives growth. Click here ...
Our research team assigns Neutral ratings to strategies they’re not confident will outperform a relevant index, or most peers, over a market cycle on a risk-adjusted basis. Managers Richard ...
After hours: 12 March at 7:59:56 pm GMT-4 Loading Chart for JNJ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback